Diagnostic Challenges of Hemophagocytic Lymphohistiocytosis

Clinical Lymphoma, Myeloma and Leukemia

Volumn 17, Issue , 2017, Pages S105-S110

  Otrock, Zaher K ^a   Daver, Naval ^b   Eby, Charles S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adult; Criteria; Diagnosis; HLH; Sepsis

Indexed keywords

FERRITIN; INTERLEUKIN 2 RECEPTOR ALPHA;

CYTOPENIA; ERYTHROPHAGOCYTOSIS; FEVER; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; NATURAL KILLER CELL; PRACTICE GUIDELINE; REVIEW; SPLENOMEGALY; ADULT; CHILD; DIFFERENTIAL DIAGNOSIS; HEMATOLOGIC DISEASE; INFECTION;

ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC NEOPLASMS; HUMANS; INFECTION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC;

EID: 85026539664     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2017.02.017     Document Type: Review

References (57)

1. Risma, K., Jordan, M.B., Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr 24 (2012), 9–15.
2. Henter, J.I., Elinder, G., Söder, O., Ost, A., Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80 (1991), 428–435.
3. Niece, J.A., Rogers, Z.R., Ahmad, N., Langevin, A.M., McClain, K.L., Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatr Blood Cancer 54 (2010), 424–428.
4. Larroche, C., Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment. Joint Bone Spine 79 (2012), 356–361.
5. Gupta, A., Tyrrell, P., Valani, R., Benseler, S., Weitzman, S., Abdelhaleem, M., The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 51 (2008), 402–404.
6. Ho, C., Yao, X., Tian, L., Li, F.Y., Podoltsev, N., Xu, M.L., Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol 141 (2014), 62–71.
7. Naneh, O., Avčin, T., Bedina Zavec, A., Perforin and human diseases. Subcell Biochem 80 (2014), 221–239.
8. Janka, G.E., Lehmberg, K., Hemophagocytic syndromes—an update. Blood Rev 28 (2014), 135–142.
9. Henter, J.I., Elinder, G., Ost, A., Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18 (1991), 29–33.
10. Henter, J.I., Aricò, M., Egeler, R.M., et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28 (1997), 342–347.
11. Henter, J.I., Samuelsson-Horne, A., Aricò, M., et al., Histiocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100 (2002), 2367–2373.
12. Henter, J.I., Horne, A., Aricó, M., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48 (2007), 124–131.
13. Otrock, Z.K., Eby, C.S., Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 90 (2015), 220–224.
14. Delavigne, K., Bérard, E., Bertoli, S., et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica 99 (2014), 474–480.
15. Tamamyan, G.N., Kantarjian, H.M., Ning, J., et al. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes. Cancer 122 (2016), 2857–2866.
16. Parikh, S.A., Kapoor, P., Letendre, L., Kumar, S., Wolanskyj, A.P., Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 89 (2014), 484–492.
17. Li, J., Wang, Q., Zheng, W., et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine 93 (2014), 100–105.
18. Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M.A., Bosch, X., Adult haemophagocytic syndrome. Lancet 383 (2014), 1503–1516.
19. Laupland, K.B., Fever in the critically ill medical patient. Crit Care Med 37 (2009), S273–S278.
20. Sherman, J.M., Sood, S.K., Current challenges in the diagnosis and management of fever. Curr Opin Pediatr 24 (2012), 400–406.
21. Wilhelm, M.C., Jones, R.E., McGehee, R., Mitchener, J.S., Sandusky, W.R., Hess, C.E., Splenectomy in hematologic disorders: the ever-changing indications. Ann Surg 207 (1988), 581–589.
22. Pozo, A.L., Godfrey, E.M., Bowles, K.M., Splenomegaly: investigation, diagnosis and management. Blood Rev 23 (2009), 105–111.
23. O'Reilly, R.A., Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995; 1963 to 1995: 449 patients. West J Med 169 (1998), 88–97.
24. Swaroop, J., O'Reilly, R.A., Splenomegaly at a university hospital compared to a nearby county hospital in 317 patients. Acta Haematol 102 (1999), 83–88.
25. Janka, G.E., Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140 (1983), 221–230.
26. Zoller, E.E., Lykens, J.E., Terrell, C.E., et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 208 (2011), 1203–1214.
27. Henter, J.I., Carlson, L.A., Söder, O., Nilsson-Ehle, P., Elinder, G., Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80 (1991), 675–681.
28. Knovich, M.A., Storey, J.A., Coffman, L.G., Torti, S.V., Torti, F.M., Ferritin for the clinician. Blood Rev 23 (2009), 95–104.
29. Esumi, N., Ikushima, S., Todo, S., Imashuku, S., Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis: a survey of pediatric cases. Acta Paediatr Scand 78 (1989), 268–270.
30. Allen, C.E., Yu, X., Kozinetz, C.A., McClain, K.L., Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 50 (2008), 1227–1235.
31. Lehmberg, K., McClain, K.L., Janka, G.E., Allen, C.E., Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 61 (2014), 2101–2103.
32. Lin, T.F., Ferlic-Stark, L.L., Allen, C.E., Kozinetz, C.A., McClain, K.L., Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 56 (2011), 154–155.
33. Schram, A.M., Campigotto, F., Mullally, A., et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125 (2015), 1548–1552.
34. Sackett, K., Cunderlik, M., Sahni, N., Killeen, A.A., Olson, A.P., Extreme hyperferritinemia: causes and impact on diagnostic reasoning. Am J Clin Pathol 145 (2016), 646–650.
35. Gauvin, F., Toledano, B., Champagne, J., Lacroix, J., Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med 28 (2000), 3341–3345.
36. Wiwanitkit, V., Bone marrow leishmaniasis: a review of situation in Thailand. Asian Pac J Trop Med 4 (2011), 757–759.
37. Inai, K., Noriki, S., Iwasaki, H., Naiki, H., Risk factor analysis for bone marrow histiocytic hyperplasia with hemophagocytosis: an autopsy study. Virchows Arch 465 (2014), 109–118.
38. Lim, S.H., Park, S., Jang, J.H., et al. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis. Ann Hematol 95 (2016), 325–335.
39. Rivière, S., Galicier, L., Coppo, P., et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 127 (2014), 1118–1125.
40. Rubin, L.A., Kurman, C.C., Fritz, M.E., et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135 (1985), 3172–3177.
41. Chilosi, M., Semenzato, G., Cetto, G., et al. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 70 (1987), 1530–1535.
42. Komp, D.M., McNamara, J., Buckley, P., Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73 (1989), 2128–2132.
43. Villanueva, J., Lee, S., Giannini, E.H., et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7 (2005), R30–R37.
44. Chung, H.J., Park, C.J., Lim, J.H., et al. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis. Int J Lab Hematol 32 (2010), 239–247.
45. Hou, H., Mao, L., Wang, J., et al. Establishing the reference intervals of NK cell functions in healthy adults. Hum Immunol 77 (2016), 637–642.
46. Johnson, T.S., Villanueva, J., Filipovich, A.H., Marsh, R.A., Bleesing, J.J., Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. J Immunol Methods 364 (2011), 1–13.
47. Sieni, E., Cetica, V., Piccin, A., et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series. PLoS One, 7, 2012, e44649.
48. Zhang, K., Jordan, M.B., Marsh, R.A., et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 118 (2011), 5794–5798.
49. Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286 (1999), 1957–1959.
50. Feldmann, J., Callebaut, I., Raposo, G., et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115 (2003), 461–473.
51. zur Stadt, U., Schmidt, S., Kasper, B., et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 14 (2005), 827–834.
52. Trottestam, H., Horne, A., Aricò, M., et al., Histiocyte Society. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118 (2011), 4577–4584.
53. Nikiforow, S., The role of hematopoietic stem cell transplantation in treatment of hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 29 (2015), 943–959.
54. Meeths, M., Chiang, S.C., Löfstedt, A., et al. Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity. Exp Cell Res 325 (2014), 10–17.
55. Besset, S., Schnell, D., Azoulay, E., Hemophagocytic lymphohistiocytosis mimicking septic shock. Chest, 141, 2012, 835.
56. Castillo, L., Carcillo, J., Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 10 (2009), 387–392.
57. Raschke, R.A., Garcia-Orr, R., Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest 140 (2011), 933–938.